CSI Market
Sign In | Register

Kiwa Bio tech Products Group (KWBT) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access KWBT Annual Cash Flow →
Examining cash flow movements between Kiwa Bio tech Products Group and Dec 31 2018 reveals how Dec 31 2019 allocates cash as operating conditions evolve.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2019)
12 Months 		(Sep 30 2019) (Jun 30 2019) (Mar 31 2019) (Dec 31 2018)
Operating Activities
Income-6.64
Depreciation & amortization0.05
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Asset Impairment Charges0.01
Provision For Loan Losses Expensed0.25
Increase (Decrease) in Inventories1.60
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.85
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Provision For Penalty Payable-
Increase Decrease In Deposits And Other Receivables-
Consulting Fee-
Accrued Interest0.25
Consulting Fee Paid By Issuance Of Common Shares-
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-
Interest Expense-
Stock Compensation For Consulting Fee-
Derivative Gain Loss On Derivative Net-
Increase Decrease In Advances From Customers-0.10
Derivative Gain On Derivative-0.08
Increase Decrease In Contract With Customer Liability-7.51
Increase Decrease In Advance To Supplier-
Income taxes2.12
Gain (Loss) on Disposition of Stock in Subsidiary3.53
Accounts Receivable-3.79
Increase (Decrease) in Accounts Payable-1.47
Accrued Expense0.74
Increase (Decrease) in Customer Advances0.00
Prepaid Expense and Other Assets0.74
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities3.10
Discontinued operations0.00
Net Cash flow from Operating Activities0.18
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Cash Disposed In Subsidiaries-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Payments to Fund Long-term Loans to Related Parties-2.07
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-2.07
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings1.63
Long-term debt - repayments-0.32
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.18
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Increase (Decrease) in Other Deposits0.00
Other financing activities net0.00
Other net0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.48
Effect of exchange rate on cash flow0.41
Discontinued operations0.00
Free Cash Flow0.18
Total Cash Flow0.00
4 historic quarters locked

Sign in to unlock the full Kiwa Bio tech Products Group cash flow history.

Sign In Create Free Account

About KWBT Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.